54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 16
00:14 UTC
|
O
Realty Income
|
◎ Target | John Kilichowski ★★★☆☆ #1514 | Equal Weight | $64.00→ $65.00+1.6% |
|
Jul 16
00:14 UTC
|
NRG
NRG Energy
|
◎ Target | Andrew Weisel ★★★★☆ #742 | Sec→ r Outperform | $223.00→ $226.00+1.3% |
|
Jul 16
00:14 UTC
|
NP
Neptune Insurance
|
◎ Target | Paul Newsome ★★★☆☆ #1567 | Overweight | $30.00→ $39.00+30.0% |
|
Jul 16
00:14 UTC
|
NNN
NNN REIT
|
◎ Target | John Kilichowski ★★★☆☆ #1514 | Equal Weight | $45.00→ $49.00+8.9% |
|
Jul 16
00:14 UTC
|
NHP
National Healthcare Properties
|
◎ Target | John Kilichowski ★★★☆☆ #1514 | Overweight | $16.00→ $17.00+6.2% |
|
Jul 16
00:14 UTC
|
NET
Cloudflare
|
◎ Target | Gregg Moskowitz ★★★☆☆ #1367 | Outperform | $260.00→ $310.00+19.2% |
|
Jul 16
00:14 UTC
|
MTB
M&T Bank
|
◎ Target | Dave Rochester ★★★☆☆ #1876 | Overweight | $253.00→ $262.00+3.6% |
|
Jul 16
00:14 UTC
|
MSFT
Microsoft
|
◎ Target | Michael Turrin ★★★☆☆ #1539 | Overweight | $650.00→ $625.00-3.8% |
|
Jul 16
00:14 UTC
|
MSFT
Microsoft
|
◎ Target | Tyler Radke ★★★☆☆ #1614 | Buy | $620.00→ $570.00-8.1% |
|
Jul 16
00:14 UTC
|
MSFT
Microsoft
|
◎ Target | Gregg Moskowitz ★★★☆☆ #1367 | Outperform | $515.00→ $490.00-4.9% |
|
Jul 16
00:14 UTC
|
MRX
Marex Group plc Ordinary Shares
|
◎ Target | Patrick Moley ★★★☆☆ #1430 | Overweight | $55.00→ $75.00+36.4% |
|
Jul 16
00:14 UTC
|
MLM
Martin Marietta Materials
|
◎ Target | Patrick Tyler Brown not yet tracked | Outperform | $690.00→ $675.00-2.2% |
|
Jul 16
00:14 UTC
|
MKTX
MarketAxess
|
◎ Target | Patrick Moley ★★★☆☆ #1430 | Neutral | $175.00→ $128.00-26.9% |
|
Jul 16
00:14 UTC
|
MFC
Manulife Financial
|
◎ Target | firm only | Sec→ r Outperform | C$56.00→ C$61.00+8.9% |
|
Jul 16
00:14 UTC
|
MFC
Manulife Financial
|
◎ Target | firm only | C$61.00→ C$69.00+13.1% | |
|
Jul 16
00:14 UTC
|
MELI
MercadoLibre
|
◎ Target | Joao Pedro Soares not yet tracked | Neutral | $1,950.00→ $2,000.00+2.6% |
|
Jul 16
00:14 UTC
|
MDA
MDA Space
|
◎ Target | firm only | Buy | C$70.00→ C$72.00+2.9% |
|
Jul 16
00:14 UTC
|
MDA
MDA Space
|
◎ Target | firm only | C$67.00→ C$59.00-11.9% | |
|
Jul 16
00:14 UTC
|
MCD
McDonald's
|
◎ Target | Jon Tower ★★★☆☆ #1732 | Buy | $375.00→ $335.00-10.7% |
|
Jul 16
00:14 UTC
|
MANE
Veradermics
|
◎ Target | Serge Belanger ★★★☆☆ #1576 | Buy | $136.00→ $164.00+20.6% |
|
Jul 16
00:14 UTC
|
MAGN
Magnera
|
◎ Target | Gabe Hajde not yet tracked | Equal Weight | $13.00→ $16.00+23.1% |
|
Jul 16
00:14 UTC
|
LVS
Las Vegas Sands
|
◎ Target | Daniel Politzer ★★★☆☆ #2000 | Overweight | $68.00→ $64.00-5.9% |
|
Jul 16
00:14 UTC
|
LSTR
Landstar System
|
◎ Target | Lucas Servera ★★★☆☆ #1923 | Hold | $190.00→ $205.00+7.9% |
|
Jul 16
00:14 UTC
|
LPX
Louisiana-Pacific
|
◎ Target | Michael Roxland ★★☆☆☆ #2427 | Buy | $93.00→ $91.00-2.2% |
|
Jul 16
00:14 UTC
|
LOB
Live Oak Bancshares
|
◎ Target | Dave Rochester ★★★☆☆ #1876 | Neutral | $41.00→ $44.00+7.3% |
|
Jul 16
00:14 UTC
|
LNTH
Lantheus
|
◎ Target | Anthony Petrone ★★★★☆ #848 | Outperform→ Market Outperform | $115.00→ $120.00+4.3% |
|
Jul 16
00:14 UTC
|
LNG
Cheniere Energy
|
◎ Target | Theresa Chen ★★☆☆☆ #2365 | Overweight | $271.00→ $274.00+1.1% |
|
Jul 16
00:14 UTC
|
LMND
Lemonade
|
◎ Target | Paul Newsome ★★★☆☆ #1567 | Neutral | $62.00→ $75.00+21.0% |
|
Jul 16
00:14 UTC
|
LLY
Eli Lilly and Company
|
◎ Target | Geoff Meacham ★☆☆☆☆ #2930 | Buy | $1,500.00→ $1,600.00+6.7% |
|
Jul 16
00:14 UTC
|
LIVN
LivaNova
|
◎ Target | Anthony Petrone ★★★★☆ #848 | Outperform | $90.00→ $95.00+5.6% |
|
Jul 16
00:14 UTC
|
LGND
Ligand Pharmaceuticals
|
◎ Target | Douglas Miehm ★★★☆☆ #1345 | Outperform | $262.00→ $340.00+29.8% |
|
Jul 16
00:14 UTC
|
LEN
Lennar
|
◎ Target | Anthony Pettinari ★★★☆☆ #1221 | Neutral | $104.00→ $88.00-15.4% |
|
Jul 16
00:14 UTC
|
LDI
loanDepot
|
◎ Target | Ryan Nash ★★★★★ #231 | Sell | $2.10→ $1.25-40.5% |
|
Jul 16
00:14 UTC
|
LAD
Lithia Motors
|
◎ Target | John Babcock ★★☆☆☆ #2809 | Overweight | $370.00→ $360.00-2.7% |
|
Jul 16
00:14 UTC
|
KOF
Coca Cola Femsa
|
◎ Target | Lucas Ferreira ★★☆☆☆ #2914 | Neutral | $114.00→ $127.00+11.4% |
|
Jul 16
00:14 UTC
|
KMTS
Kestra Medical Technologies
|
◎ Target | Marie Thibault ★★★☆☆ #2100 | Buy | $30.00→ $32.00+6.7% |
|
Jul 16
00:14 UTC
|
KHC
Kraft Heinz
|
◎ Target | Thomas Palmer ★★★☆☆ #1346 | Underweight | $21.00→ $22.00+4.8% |
|
Jul 16
00:14 UTC
|
KEY
Keyera
|
◎ Target | firm only | C$53.00→ C$56.00+5.7% | |
|
Jul 16
00:14 UTC
|
JPM
JPMorgan Chase & Co.
|
◎ Target | Gerard Cassidy ★★☆☆☆ #2398 | Outperform | $330.00→ $370.00+12.1% |
|
Jul 16
00:14 UTC
|
JPM
JPMorgan Chase & Co.
|
◎ Target | David George ★★★★☆ #589 | Neutral | $295.00→ $305.00+3.4% |
|
Jul 16
00:14 UTC
|
JPM
JPMorgan Chase & Co.
|
◎ Target | Jason Goldberg ★★☆☆☆ #2838 | Overweight | $391.00→ $420.00+7.4% |
|
Jul 16
00:14 UTC
|
JPM
JPMorgan Chase & Co.
|
◎ Target | Mike Mayo ★★☆☆☆ #2426 | Overweight | $360.00→ $375.00+4.2% |
|
Jul 16
00:14 UTC
|
JPM
JPMorgan Chase & Co.
|
◎ Target | David Konrad ★★★☆☆ #1481 | Outperform | $370.00→ $384.00+3.8% |
|
Jul 16
00:14 UTC
|
JPM
JPMorgan Chase & Co.
|
◎ Target | John McDonald not yet tracked | Hold | $344.00→ $352.00+2.3% |
|
Jul 16
00:14 UTC
|
JD
JD.com
|
◎ Target | Jiong Shao ★★★☆☆ #1286 | Overweight | $43.00→ $41.00-4.7% |
|
Jul 16
00:14 UTC
|
JBHT
J.B. Hunt Transport Services
|
◎ Target | Lucas Servera ★★★☆☆ #1923 | Hold | $230.00→ $280.00+21.7% |
|
Jul 16
00:14 UTC
|
JAN
JAN
|
◎ Target | John Kilichowski ★★★☆☆ #1514 | Overweight | $31.00→ $33.00+6.5% |
|
Jul 16
00:14 UTC
|
IP
International Paper
|
◎ Target | Michael Roxland ★★☆☆☆ #2427 | Buy | $40.00→ $46.00+15.0% |
|
Jul 16
00:14 UTC
|
IOF
Iofina
|
◎ Target | firm only | Buy | GBX 60→ GBX 65+8.3% |
|
Jul 16
00:14 UTC
|
INSM
Insmed
|
◎ Target | Benjamin Burnett ★★☆☆☆ #2751 | Overweight | $160.00→ $161.00+0.6% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.